Home
Insights
Dashboard
EU Projects
Companies
European Innovation Council
Funding
Corporates
Universities
Resources
Companies
Wuxi Zhikang Hongyi Biotechnology
Save
Wuxi Zhikang Hongyi Biotechnology
Innovative oncology solutions with advanced WEE1 inhibitors for late-stage ovarian cancer treatment.
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Recent News about Wuxi Zhikang Hongyi Biotechnology
Edit